While functional imaging and deep brain stimulation studies point to a pivotal role of the hypothalamus in the pathophysiology of migraine and trigeminal autonomic cephalalgias, the circuitry and the mechanisms underlying the modulation of medullary trigeminovascular (Sp5C) neurons have not been fully identified. We investigated the existence of a direct anatomo-functional relationship between hypothalamic excitability disturbances and modifications of the activities of Sp5C neurons in the rat. Anterograde and retrograde neuronal anatomical tracing, intrahypothalamic microinjections, extracellular single-unit recordings of Sp5C neurons, and behavioral trials were used in this study. We found that neurons of the paraventricular nucleus of the hypothalamus (PVN) send descending projections to the superior salivatory nucleus, a region that gives rise to parasympathetic outflow to cephalic and ocular/nasal structures. PVN cells project also to laminae I and outer II of the Sp5C. Microinjections of the GABA A agonist muscimol into PVN inhibit both basal and meningeal-evoked activities of Sp5C neurons. Such inhibitions were reduced in acutely restrained stressed rats. GABA A antagonist gabazine infusions into the PVN facilitate meningeal-evoked responses of Sp5C neurons. PVN injections of the neuropeptide pituitary adenylate cyclase activating peptide (PACAP38) enhance Sp5C basal activities, whereas the antagonist PACAP6-38 depresses all types of Sp5C activities. 5-HT1 B/D receptor agonist naratriptan infusion confined to the PVN depresses both basal and meningeal-evoked Sp5C activities. Our findings suggest that paraventricular hypothalamic neurons directly control both spontaneous and evoked activities of Sp5C neurons and could act either as modulators or triggers of migraine and/or trigeminal autonomic cephalalgias by integrating nociceptive, autonomic, and stress processing mechanisms.
Introduction
Preclinical data suggest that primary headaches are initiated by the activation of meningeal perivascular nociceptors that in turn activate brainstem trigeminovascular (Sp5C) neurons (Burstein et al., 1998) . Although the mechanisms by which the trigeminovascular pathway become activated in the first place have not been fully established, there is a variety of endogenous headache triggers such as hypothalamic-related maladaptive changes that have been proposed as a common determinant factor on the susceptibility to both migraine (Zurak, 1997; Alstadhaug, 2009) and trigeminal autonomic cephalalgias (TACs) (Leone et al., 2001; May, 2009) .
Cranial autonomic manifestations, including reddening of the eye, tearing, rhinorrhea, and eyelid edema, which commonly accompany TACs and to a lesser extent migraine, are likely mediated by dysfunctional changes in hypothalamic structures that integrate and drive autonomic responses. In addition, the episodic nature of migraine attacks and TACs has been related to circadian rhythmicity, hormonal fluctuations, and stress, further implicating hypothalamic involvement in the initiation of the headache. Likewise, functional imaging studies have clearly observed hypothalamic abnormal activity during migraine (Denuelle et al., 2007) and the different types of TACs (May et al., 1998 (May et al., , 1999 Matharu et al., 2004 Matharu et al., , 2006 . A proof of concept for has been established through the therapeutically effective use of posterior hypothalamic stimulation in TACs patients (Leone et al., 2001) . However, the specific hypothalamic mechanisms involved in the initiation of the headache and autonomic outflow during migraine and TACs remain to be explored.
The overall aim of this study was to investigate the existence of a direct relationship between hypothalamic excitability disturbances and the activities of rat Sp5C neurons involved in meningeal nociceptive processing. For this purpose, we studied the functional architecture of hypothalamic networks that could directly modulate brainstem Sp5C neurons. Initially, we examined the fine topographic organization of hypothalamo-trigeminal projections with high-resolution retrograde and anterograde anatomical tracing under electrophysiological control. On the basis of the resulting data, additional series of experiments were designed to perform extracellular recordings of Sp5C neurons. In one set of experiments, basal activities and Sp5C-evoked responses following meningeal electrical stimulation were recorded before and after GABAergic, pituitary adenylate cyclase activating peptide (PACAP), and 5-HT1 B/D receptor agonist (naratriptan) microinjections within the paraventricular nucleus of the hypothalamus (PVN). In another experimental series, the GABA A agonist muscimol was microinjected within the PVN in an acute restrained stress model to investigate whether top-down influences from the PVN onto Sp5C neurons are modified by stress.
Parts of this paper have been published previously in abstract form Robert et al., 2012) .
Materials and Methods
General. Adult male Sprague Dawley rats (Charles River Laboratories) weighing 200 -300 g were used in this study. All animal experiments were approved by our local animal care committee and were in accordance with the guidelines of the International Association for the Study of Pain (Zimmermann, 1983) .
Electrophoretic injections of the retrograde tracer Fluorogold into Sp5C. The rats were anesthetized with chloral hydrate (400 mg/kg, i.p.) and mounted in a stereotaxic device. The atlanto-occipital membrane and the overlying dura were removed. Glass micropipettes (40 m diameter tips) filled with a 2% solution of hydroxystilbamidine (Fluorogold; Interchim) were positioned at 2700 -4000 m caudal to the obex and inserted into the ventrolateral aspect of the Sp5C. Multiunitary recordings of cells responding to tactile and noxious pinch stimuli of the ophthalmic dermatome of the trigeminal nerve were performed. Once these cells were encountered, direct positive currents (6 -10 A, on-off cycles of 10 s) were applied for 15 min. Then, the surgical wounds were sutured and disinfected. Each animal was kept in an individual cage for 72 h and reanesthetized with an overdose of chloral hydrate (800 mg/kg, i.p.) and perfused with 200 ml of warm (37°C) heparinized saline, followed by 500 ml of PBS (0.2 M), pH 7.3, containing 4% paraformaldehyde and 0.05% picric acid. The brain and medulla were removed and soaked in the latter solution for 2 h and then cryoprotected in a buffered 30% sucrose solution. Two days later, 40-m-thick coronal sections were rinsed with PBS and divided into three groups. The sections of one group were preincubated for 1 h in a blocking solution of PBS containing 0.3% Triton X-100 and 0.3% bovine serum albumin (PBT) and 2% normal goat serum (NGS). They were then incubated overnight in the primary antibody, namely, 1:5000 rabbit anti-Fluorogold (Millipore Bioscience Research Reagents) in PBT and 2% NGS. After 20 min rinsing with PBS, the sections were incubated for l h in the secondary antiserum, namely, l:200 biotinylated goat anti-rabbit IgG (Interchim) in PBT and 2% NGS. After rinsing with PBS, the sections were processed for ABC/ DAB (Vector Laboratories) to localize the retrograde labeling in different brain structures.
Electrophoretic injections of the anterograde tracer biotin dextran into the PVN. The rats were anesthetized with chloral hydrate (400 mg/kg, i.p.) and mounted in a stereotaxic device, and a craniotomy was performed. Glass micropipettes (40 m diameter tips) filled with a 10% solution of biotin dextran (BD; 10,000 molecular weight; Invitrogen) were inserted into the the parvocellular aspect of the PVN 800 -1200 m caudal to bregma, 1900 -2300 m lateral to the midline, at a depth of 7200 -7800 m (Paxinos and Watson, 1998). Once the micropipette was placed in the desired position, direct positive current (2-4 A) was applied for 20 s Figure 1 . Paraventricular hypothalamic neurons retrogradely labeled from the ophthalmic branch of the Sp5C. A, Camera lucida drawings of coronal sections, illustrating the location and extent of all FG injection sites (gray, selected site in black) into the Sp5C/C1 area containing dura-sensitive neurons with periocular receptive fields, recorded before a Fluorogold injection.
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B, Photomicrograph of the selected site. C, Retrogradelly labeled cells in the hypothalamus (adapted from Paxinos and Watson, 1983) . Note that labeled cells were confined to the ipsilateral parvocellular region of the PVN, covering between Ϫ2.12 and Ϫ1.80 mm caudal to bregma. All of these injection sites provided similar patterns of retrograde labeling within the PVN. Scale bars, 100 m. PaDC, Paraventricular hypothalamic nucleus, dorsal cap; PaLM, paraventricular hypothalamic nucleus, lateral magnocellular part; PaMP, paraventricular hypothalamic nucleus, medial parvicellullar part; PaPo, paraventricular hypothalamic nucleus, posterior part; ventral part; CC, central canal; Cu, cuneate nucleus; Gr, gracile nucleus; PaV, paraventricular hypothalamic nucleus. Numbers indicate distance from bregma. every 30 s for 15-20 min. Following a postoperative survival period of 1 week, the animals were reanesthetized and perfused as described previously (Noseda et al., 2008) . The brain and medulla were removed, postfixed, and cryoprotected. Two days later, the 40-m-thick coronal sections were rinsed with PBS. The sections were divided into three groups. Two groups were processed for ABC/DAB histochemistry to localize the anterograde labeling in different brain structures; one of these groups was counterstained with cresyl violet.
Analysis of the retrograde and anterograde labeling. In all the tracttracing experimental series, the injection sites, labeled cell bodies, fibers, varicosities, and boutons were examined under bright-and dark-field illumination. Each injection site was analyzed using camera lucida drawings of coronal sections processed with DAB. Representative cases including the full extents of the injection sites were grouped on standard drawings of the caudal medulla and PVN areas. Bright-field photomicrographs of the injection sites and representative labeling were built as digitized gray scale images using computer-assisted reconstruction of labeling. The technique used has been described in detail previously (Villanueva and Le Bars, 1993) . The delineation and nomenclature of brainstem and supramedullary areas were based on the atlas of Paxinos and Watson (1998) . The areas of interest were also fully identified in our counterstained material.
Unitary extracellular recordings. Rats were introduced in a chamber and deeply anesthetized with 2.5% isofluorane (1000 mg/ml solution; Virbac) placed in a vaporizer that mixes the anesthetic solution with air. Cannulas were inserted into the trachea, a carotid artery, and a jugular vein. Once the animals were intubated following tracheostomy, the anesthetic mixture was delivered at a rate of 100 ml/min. The rats were paralyzed by intravenous injection of gallamine triethiodide (10 mg/h; Rhone-Poulenc Rorer) and artificially ventilated at a rate of 52 strokes/ min. The stroke volume was adjusted to maintain a normal acid-base equilibrium assessed using a Datex-Ohmeda (GE Healthcare) compact monitor. This capnometer continuously measured respiratory frequency, end-tidal, inspired and expired CO 2 , O 2 , and isofluorane levels via a catheter in the tracheal space. These parameters were displayed digitally, and each was under the control of an alarm. Each animal was mounted in a stereotaxic frame, and a craniotomy was performed at the lambdoid suture on the right side of the skull to allow placement of a stimulating electrode on the dura overlying the transverse sinus. A second craniotomy was performed on the right side of the skull [1.4 mm behind the coronal suture; 2.5 mm lateral to the midline, according to the coordinates of Paxinos and Watson (1998) ] to access the hypothalamus for drug microinjections. The atlanto-occipital membrane was removed, and a partial laminectomy of C1 was done to allow access to the caudal brainstem/cervicomedullary junction, where most of the trigeminovascular cells responding to the dura are located (Burstein et al., 1998; Noseda et al., 2010) . Once the surgical procedures were finished, the level of anesthesia was lowered to 1.5% isofluorane. Extracellular single units were recorded using glass micropipettes or quartz-insulated, platinumtungsten microelectrodes custom ground to impedances of 4 -6 M⍀. In the latter case, five electrodes were positioned 300 m apart in the mediolateral axis on the Sp5C/C1 region between 2700 and 4000 m caudal to the obex and advanced into the brainstem independently using a five-channel Eckhorn mini-matrix microdrive system (Thomas Recordings). This device allows the insertion of thin shaft probes into neural tissue by a stretched elastic rubber tube in which the quartz-insulated, platinum-tungsten electrodes are guided (Eckhorn and Thomas, 1993) . This system enables smooth movements performed with independently advanceable electrodes. Moreover, the electrodes are quite thin (60 m shaft; 10 m tip diameters), but strong enough to penetrate the dura, thus reducing the damage to the neural tissue. Microelectrode signals were amplified, filtered, digitized, and discriminated with a CED hardware and Spike 2 software (version 7, Cambridge Electronic Design). Raw and discriminated signals were fed through an audio monitor and displayed on an oscilloscope for additional inspection. Waveforms and recorded spike trains were stored on computer disk for off-line analyses. Baseline and evoked activities of trigeminovascular neurons were recorded and analyzed as cumulative frequency and poststimulus histograms (PSTHs), to detect the occurrence of statistically significant neuronal responses. PSTH analysis of noxious meningeal stimulation was expressed as the total number of spikes triggered by trains of single electrical pulses. On the basis of the literature (Levy and Strassman, 2002) , and taking into account the distance between the stimulated area and the recording electrode, the peak latencies observed in our study correspond to peripheral conduction velocities within the A␦-and C-fiber ranges, respectively. Accordingly, we used time frame windows of 0 -30 ms and 30 -100 ms for measuring A␦-and C-fibers activities, respectively, and 100 -150 ms for afterdischarges. Background neuronal discharges were expressed in hertz.
Intrahypothalamic administration of drugs. We tested the effects of a GABA A agonist and antagonist (muscimol, 8.7 mM, 200 nl; gabazine, 50 M, 200 nl dissolved in saline; Sigma-Aldrich), pituitary adenylate cyclase activating peptide agonist and antagonist (PACAP38, 50 M, 500 nl; PACAP6 -38, 200 M, 500 nl dissolved in saline; Bachem), and naratriptan (10 M, 200 nl dissolved in saline; Sigma-Aldrich) within the parvocellular part of the PVN on baseline and evoked trigeminovascular neuronal responses. Drugs were injected at a rate of 1 nl/s using a Hamilton syringe (200 m tip) driven by an electronic geared syringe pump (Ultra Micropump, UMP3; WPI) that allowed us to minimize the damage to the brain tissue. The specificity of the paraventricular hypothalamic effects of all drugs tested was confirmed by the systematic lack of changes on both Sp5C activities and physiological parameters (respiratory, cardiovascular) following microinjections placed adjacent to PVN regions projecting to Sp5C (see Fig. 3 ). At the conclusion of the experiments, the recording and microinjection sites were marked by deposition of 500 nl of pontamine sky blue and examined in Nissl-counterstained tissue.
Experimental design: innocuous and noxious stimulation. A first search of cells responding to tactile stimulation of the ophthalmic dermatome of the trigeminal nerve was performed. Once these clusters of Sp5C cells were encountered, a systematic search was performed for dura-sensitive Sp5C neurons responding to electrical stimulation (1 Hz; 0.8 ms duration; 1 mA) of the transverse sinus (see Fig. 3 ). Once a neuron responding to such search stimuli was found, a 10 -20 min resting period was allowed to permit the neuron to return to its steady-state baseline activity, thus making possible accurate measurements of preinjection, control background activities. Mean background activity was calculated for each cell from a 200 s period before each test. Sets of controls consisting of measurements of baseline activity followed by meningeal electrical stimuli (approximately onefold C-fiber threshold intensity) were applied before microinjections into PVN. Postinjection tests were performed at 5 min intervals during 60 -120 min to observe the effects of each drug and the temporal evolution of spontaneous and evoked activities of Sp5C neurons.
Stress protocol. The behavioral stress protocol used in this study was described previously (Xu et al., 1998; Rocher et al., 2004) . Briefly, rats (n ϭ 8) were placed on an elevated and unsteady platform (21 ϫ 20 cm) for 30 min. The platform was positioned 1 m above the ground and illuminated at a 50 cm distance with a high-intensity light source (1500 lux). While on the platform, all animals showed signs of stress such as increased urination, defecation, grooming, and freezing. Ten minutes after the stress procedure, rats were anesthetized with a mixture of 2.5% isoflurane and air. Following anesthesia and before surgery, blood samples of control and stressed animals were collected from the orbital sinus. As a biomarker of stress, plasma levels of corticosterone were determined using an enzyme immunoassay (ELISA Kit ADI-900-097; Enzo Life Sciences). According to the manufacturer's protocol, the intra-assay coefficient of variation was 6.6%, and the sensitivity was 27.0 pg ml Ϫ1 . Rats were then prepared for electrophysiological recordings as described above. Statistical analysis. One dura-sensitive neuron was studied per animal. Cumulative results are expressed as the mean Ϯ SEM of the percentage changes with regard to the mean values obtained before the cortical manipulation. Analyses were performed by comparing predrug and postdrug scores using Student's t test and a two-tailed Wilcoxon signed rank test. Paired Student's t test was also performed to determine significance between control and peak responses. The global impact of stress on muscimol effects was assessed from the areas under curves (AUCs) processed with two-way ANOVA followed by Bonferroni's post hoc multiple comparison tests. The levels of significance were set at p Ͻ 0.05 and p Ͻ 0.01.
Results

Topographic organization of hypothalamo-trigeminal pathways
Hypothalamic regions projecting to functionally characterized Sp5C trigeminovascular neurons were identified following iontophoretic injections of the retrograde tracer FG under electrophysiological control (Fig. 1A) . All of these injection sites provided similar patterns of retrograde labeling within the PVN. We selected a small size injection site for presentation purposes. As shown in previous studies (Burstein et al., 1998; Noseda et al., 2010) , neurons driven by meningeal and cutaneous periocular inputs are mainly located in the ventral Sp5C and upper cervical segments of the spinal cord (C1/C2). Injections of FG into Sp5C/C1 produced dense retrograde labeling of a cluster of cells located in the dorsomedial capsular, ventral, and posterior parts of the parvocellular aspect of the PVN, ipsilateral to the injection sites (Fig. 1C) . These clusters of hypothalamo-trigeminal cells were observed in an area extending between Ϫ2.12 and Ϫ1.80 mm caudal to bregma, respectively (Paxinos and Watson, 1998). We also observed some retrograde labeled cells in other hypothalamic regions. Qualitative analyses of each rat showed that, compared to PVN, the amount of labeled neurons was very low, including scattered cells in the lateral hypothalamus and A11 region, and some few cells in the perifornical and retrochiasmatic nuclei.
Since FG can be taken and transported avidly by axons passing through, but not terminating in the injection sites (Dado et al., 1990) , it is possible to obtain "false positive" retrograde labeling. To avoid this problem and to determine precisely the organization and distribution of PVN afferents in Sp5C/C1, the anterograde tracer BD was injected into the hypothalamic areas retrogradely labeled from Sp5C. Based on their restricted sizes and locations, representative cases were selected and further analyzed by comparing the pattern of labeling in the caudal medulla. Although a systematic study of anterograde tracer injections located in PVN regions neighboring to the area retrogradely labeled from Sp5C was not performed, we did not observe descending projections to the Sp5C when some injection sites were located in these regions. Injections into PVN (Fig. 2B ) resulted in dense labeling of fibers that terminated in the ipsilateral brainstem. Axonal terminal labeling consisting of thin fibers and small varicosities was restricted to Sp5C laminae I and outer II throughout its caudalmost aspect, including C1/C2 (Fig. 2C) . Terminal labeling was also observed rostrally in the superior salivatory nucleus (SSN) (Fig. 2D ). In agreement with previous anterograde tracing studies (Geerling et al., 2010) , we also observed brainstem projections to other areas implicated in pain processing, including the ventrolateral periaqueductal gray matter (vPAG), the locus ceruleus and the parabrachial nucleus. 
Selective hypothalamic modulation of Sp5C trigeminovascular activities
Sp5C neurons presented a variable, mean tonic background activity of 30.5 Ϯ 5.4 Hz and were driven by both electrical stimulation of the dura and periocular brushing. Cumulative results revealed that supramaximal electrical stimulation of the dura (mean intensity, 0.8 Ϯ 0.07 mA) produced both an early (7 Ϯ 0.1 ms) and late (45 Ϯ 0.6 ms) peak of activation. Such latencies correspond to peripheral conduction velocities within the A␦-fiber (4.3 m/s) and C-fiber (0.7m/s) ranges, respectively (Noseda et al., 2010) . Afterdischarges were also observed following repetitive electrical meningeal stimulation. Such increased responses were probably elicited by temporal summation mechanisms termed windup, a progressive increase in nociceptive trigeminal or spinal dorsal horn neuronal responses following repeated electrical stimulation of C-fibers, at a fixed intensity. Windup is thought to result from the temporal summation of NMDAreceptor-mediated slow cumulative depolarizations evoked by cutaneous nociceptive primary afferent input (D'Mello et al., 2011) . Although windup does not amplify meningeal-evoked baseline responses (Bolton et al., 2005) , it is possible that under our experimental conditions such temporal summation mechanisms elicited Sp5C prolonged excitability, since afterdischarges occurred even though the magnitude of peripheral input remained the same. As shown in the individual example (Fig. 4A) , microinjections of the GABA A agonist muscimol within PVN strongly reduced both background, A␦-and C-fiber dura-evoked responses of the simultaneously recorded Sp5C neuron 5-10 min after the hypothalamic microinjection. Cumulative results showed that background and meningeal A␦-and C-fiber evoked responses were significantly depressed by 43.7 Ϯ 10.4%, 81.1 Ϯ 6.8%, and 60.2 Ϯ 11.7% of the control values, respectively, 20 min after muscimol, and lasted throughout the 60 min postinjection period (Fig 4C,D ; Table 1 ).
Microinjections of the GABA A antagonist gabazine within PVN elicit an enhancement of meningeal evoked activities of Sp5C neurons 5-10 min after the hypothalamic microinjection (Fig. 5A ). Cumulative results (Fig. 5C,D ; Table 1) showed that facilitations were observed between 5-50 min after an injection. Meningeal A␦-and C-fiber-evoked responses were significantly enhanced to 119.6 Ϯ 6.3% and 121.2 Ϯ 9.2% of the control values respectively, 20 and 30 min, respectively, after gabazine. Background activities were reduced during the 30 min period that followed the injection, to 80.3 Ϯ 6.9% of the control values, 5 min after gabazine.
Hypothalamic PACAPergic modulation on Sp5C neurons after microinjections of the agonist PACAP38 into the PVN is shown in Figure 6 and Table 1 . As illustrated in the individual example (Fig. 6A) , microinjections of PACAP38 elicit significant enhancement of background activity of Sp5C neurons 15 min after the hypothalamic microinjection. Cumulative results showed that background activity was significantly enhanced to 142 Ϯ 17.0% of the control values 15 min after PACAP38 and lasted 60 min after microinjection (Fig. 6C,D) . Only afterdischarges elicited by meningeal stimulation were enhanced between 5 and 60 min after microinjection. (136.9 Ϯ 15.1%, 5 min after PACAP38) without modifying significantly A␦-and C-fiber meningeal-evoked responses.
Microinjections of the PACAP antagonist PACAP6 -38 within PVN depressed both background and meningeal-evoked nociceptive responses (Fig. 7) . Cumulative results ( Fig. 7C,D ; Table 1) showed that depressions of background activities were obtained at 20 min after injection and lasted throughout the whole recording period (78.4 Ϯ 10.3% at 20 min after injection). Dura-evoked activities were reduced during almost the whole period that followed the injection (76.4 Ϯ 4.3% and 70.5 Ϯ 11.6% for A␦-and C-fiber evoked responses, respectively).
Microinjections of naratriptan within PVN inhibited both background and meningeal-evoked responses of Sp5C neurons (Fig. 8) . As shown in the cumulative results ( Fig. 8C,D; Table 1 ), the depressing effects of naratriptan on background activities were significant between 30 and 60 min (82.2 Ϯ 5.8% at 30 min after naratriptan), whereas meningeal-evoked responses were depressed between 5 and 40 min after microinjection (77.2 Ϯ 5.9% and 81.1 Ϯ 5.5% for A␦ at 5 min and C-fiber at 20 min, respectively).
GABAergic-mediated hypothalamic inhibition of Sp5C trigeminovascular activities is reduced by acute stress
Rats placed on the elevated platform showed a dramatic increase in plasma corticosterone levels (200.2 Ϯ 11.6 ng/ml; n ϭ 8) compared to nonstressed rats (84.3 Ϯ 12.3 ng/ml; n ϭ 7; p Ͻ 0.015). Electrophysiological recordings from Sp5C neurons were performed within a time frame between 2 h 30 min and 5 h after acute stress procedure (Fig. 9) . As shown in Figure 9B and Table  1 , AUC calculations indicate that the depressive effects of muscimol during the complete recording period were significantly reduced in stressed as compared to control animals (784 Ϯ 177% and 1996 Ϯ 326%, respectively, for meningeal-evoked responses, p Ͻ 0.01; 1220 Ϯ 251% and 2149 Ϯ 248%, respectively, for background activity, p Ͻ 0.05).
Discussion
The present study provides precise information about the functional architecture of PVN-descending trigeminal projections that are anatomically positioned to modulate both spontaneous and meningeal-evoked activities of trigeminovascular Sp5C neurons. Since PVN neurons are activated by noxious somatosensory stimuli (Condés-Lara et al., 2009), it is possible that these cells are part of feedback loops activated by noxious meningeal stimulation. We propose that direct descending influences from PVN Geerling et al., 2010) , PVN parvocellular neurons project also to the SSN, a region that gives rise to parasympathetic outflow to cephalic and ocular/nasal structures. PVN cells could modulate SSN neuronal activity that in turn influences postganglionic parasympathetic neurons in the sphenopalatine ganglion, resulting in vasodilation, plasma protein extravasation, and local release of inflammatory molecules (Delépine and Aubineau, 1997) that activate meningeal nociceptors. In this respect, a previous study showed that SSN stimulation activates both Sp5C neurons and elicited cranial autonomic reactions, which were inhibited by drugs currently effective in TACs treatments (Akerman et al., 2012) . Interestingly, the same clusters of parvocellular PVN-trigeminal projecting cells are also densely labeled with corticotropin releasing hormone (Simmons and Swanson, 2009 ) and project to sympathetic and parasympathetic preganglionic neurons in the brainstem and spinal cord implicated in the autonomic aspect of the stress responses (Swanson and Sawchenko, 1980) . Since PVN is implicated both in neurohormonal and autonomic integration of stress responses, it could likely act as a pivotal structure coordinating and integrating pain/anxiety comorbidity mechanisms involved in several primary headaches. Moreover, it is possible that in addition to direct, monosynaptic influences of PVN cells on CNS regions implicated trigeminovascular processing (Sp5C/SSN), part of PVN descending modulation occurs also indirectly, via brainstem regions involved in pain modulation such as the vPAG.
PVN influences on brainstem trigeminovascular neurons: a direct link for top-down processing of headaches
Restricted intrahypothalamic pharmacological manipulations allowed us to determine a variety of selective, top-down PVN modulatory influences on trigeminovascular Sp5C neurons. The differences in the latency and magnitude of the effects observed could be partly due to the variability of the injection locations, the small volumes used, and the diffusion ability of each drug. Nevertheless, unspecific effects can be ruled out since microinjections of the different drugs within PVN, when effective, always produced a selective unidirectional modulation of Sp5C responses, as illustrated both in the individual examples and peak effects measured on each cell tested. We first investigated the role of GABA A receptor because PVN neurons re- ceive strong GABAergic inputs (Decavel and Van den Pol, 1990) and constitute a major fast inhibitory neurotransmitter in the PVN (Boudaba et al., 1996; Hermes et al., 1996 (Légrádi et al., 1998) , suggesting that PACAP inputs onto PVN neurons could elicit pronociceptive descending influences at the origin of headaches, while simultaneously regulating the hypothalamic-pituitary-adrenal axis (HPA) and thus stress responses. In this respect, upregulation of mRNAs encoding CRH in the PVN is PACAP dependent (Stroth et al., 2011) , and behavioral studies using PACAP injections in the PVN (Norrholm et al., 2005) showed scored behaviors of stress that were increased in restrained animals, suggesting that PACAP could act as an excitatory neuropeptide that enhances responses to stress via CRH neurons. It is possible that centrally mediated PACAP effects could participate in the delayed migraine-like attacks observed only in migraineurs following systemic administration of PACAP38 (Schytz et al., 2009) . However, some studies suggested that induction of migraine following PACAP38 infusion could be mediated peripherally, through the activation of meningeal nociceptors in the perivascular space of cranial arteries (Schytz et al., 2010) following degranulation of dural mast cells (Baun et al., 2012) . A parallel processing of both HPA and trigeminovascular activities at the PVN level is further supported by our data indicating that GABA A -mediated inhibition of the excitatory output of PVN cells onto Sp5C neurons is significantly reduced by stress in the acutely restrained group. As shown previously (Hewitt et al., 2009) , acute stress reduces the properties of GABA A -inhibitory synapses impinging on parvocellular PVN neurons by downregulating the transmembrane anion transporter KCC2, which maintains low intracellular Cl Ϫ concentration, a prerequisite for the generation of Cl Ϫ hyperpolarizing GABA A -mediated responses. Although highly speculative, it is tempting to propose that such a loss of inhibition mediated by changes in the expression of KCC2 transporter could constitute one of the maladaptive mechanisms by which headaches may be generated primarily within the hypothalamus. However, our proposal is only based on indirect evidence, and thus numerous additional studies will be necessary to investigate this hypothesis. Moreover, the depressive effects on both basal and meningealevoked Sp5C neuronal activity exerted by 5-HT1 B/D agonist naratriptan injections into the PVN could account for an entirely central mechanism. Central mechanisms at the origin of some TACs could play a fundamental role in the pathophysiology of such disorders, as shown by the persistence of cluster headache in a patient after total section of the trigeminal sensory root, which continued to respond to sumatriptan (Matharu and Goadsby, 2002) .
As a whole, these findings support the possibility of a topdown modulation conveyed by PVN cells acting either on basal Sp5C activities or activated meningeal nociceptors. Such regulation could be mediated by sensory and autonomic PVN/ trigeminal-SSN outflow mechanisms, which could be altered by stress. An important question remains whether such hypothalamic controls could be simply interpreted as putative "attack generators," since they are also likely to influence, or be influenced by, sensory information conveyed by the trigeminovascular pathway.
